rs200063331
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001077416.2(TMEM231):c.248C>A(p.Ser83*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000286 in 1,569,556 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001077416.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM231 | NM_001077418.3 | c.139+47C>A | intron_variant | ENST00000258173.11 | NP_001070886.1 | |||
TMEM231 | NM_001077416.2 | c.248C>A | p.Ser83* | stop_gained | 1/6 | NP_001070884.2 | ||
TMEM231 | NR_074083.2 | n.182+47C>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM231 | ENST00000568377.5 | c.176C>A | p.Ser59* | stop_gained | 1/6 | 1 | ENSP00000476267.1 | |||
TMEM231 | ENST00000258173.11 | c.139+47C>A | intron_variant | 1 | NM_001077418.3 | ENSP00000258173.5 | ||||
TMEM231 | ENST00000565067.5 | c.139+47C>A | intron_variant | 5 | ENSP00000457254.1 | |||||
TMEM231 | ENST00000562410.5 | n.139+47C>A | intron_variant | 1 | ENSP00000454582.1 | |||||
TMEM231 | ENST00000570006.5 | n.139+47C>A | intron_variant | 5 | ENSP00000455520.1 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152070Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000225 AC: 40AN: 177604Hom.: 0 AF XY: 0.000268 AC XY: 26AN XY: 97102
GnomAD4 exome AF: 0.000287 AC: 407AN: 1417486Hom.: 0 Cov.: 30 AF XY: 0.000265 AC XY: 186AN XY: 700782
GnomAD4 genome AF: 0.000276 AC: 42AN: 152070Hom.: 0 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74286
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | May 14, 2022 | The c.176C>A (p.S59*) alteration, located in exon 1 (coding exon 1) of the TMEM231 gene, consists of a C to A substitution at nucleotide position 176. This changes the amino acid from a serine (S) to a stop codon at amino acid position 59. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on the available evidence, this alteration is classified as likely pathogenic. - |
Joubert syndrome 20;C3809352:Meckel syndrome, type 11 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 25, 2023 | This sequence change creates a premature translational stop signal (p.Ser83*) in the TMEM231 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TMEM231 are known to be pathogenic (PMID: 23012439, 23349226). This variant is present in population databases (rs200063331, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with TMEM231-related conditions. ClinVar contains an entry for this variant (Variation ID: 565503). For these reasons, this variant has been classified as Pathogenic. - |
Joubert syndrome and related disorders Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 22, 2024 | Variant summary: TMEM231 c.248C>A (p.Ser83X) results in a premature termination codon, predicted to cause absence of the protein due to nonsense mediated decay, which is a commonly known mechanism for disease. The variant allele was found at a frequency of 0.00023 in 177604 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in TMEM231 causing Joubert Syndrome And Related Disorders (0.00023 vs 0.0004), allowing no conclusion about variant significance. To the best of our knowledge, c.248C>A has been not reported in the literature in individuals affected with Joubert Syndrome And Related Disorders, but in an individual with Congenital Stationary Night Blindness, this variant was reported as an additional finding, together with a pathogenic NYX variant that may fully explain the eye phenotype (Zhu_2022). These report(s) do not provide unequivocal conclusions about association of the variant with Joubert Syndrome And Related Disorders. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 35456422). ClinVar contains an entry for this variant (Variation ID: 565503). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at